Empagliflozin Protects against Pulmonary Ischemia/Reperfusion Injury via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent Mechanism.
J Pharmacol Exp Ther
; 380(3): 230-241, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34893552
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Reperfusion Injury
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
Limits:
Animals
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2022
Type:
Article
Affiliation country:
Slovenia